Harvard's free programming classes teach you how to think, debug, and adapt in an AI-driven world where knowing code matters more than ever.

My coding skills leave something to be desired. I never stuck with the instructional books and guides long enough to truly create the kinds of apps and programs I wanted to see. AI chatbots powered by ...

Palantir has been one of the best growth stories in the market. UiPath is just beginning to see its revenue growth accelerate ...

Fourth graders participate in an introductory lesson on artificial intelligence during a computer applications class at Dr.

Toward the end of this decade, a choice may face the species that could reshape its interactions with intelligence itself and ...

The new tool injects real-time budget awareness into agent reasoning loops, tackling runaway compute and tool calls.

November's wave of FDA oncology approvals signals the industry's shift toward platform-based precision therapies over broad-spectrum approaches([1]) . The global anticancer drug market now values ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...